Search

everythinglearnresearchcommunity

for

Search:↓

Burn reconstruction improves with new techniques, materials, and tissue engineering.

Different types of PCOS have different levels of metabolic problems, with the most severe type showing the highest disturbances.

The research found that anovulatory young women have higher androgen and hormone levels than those who ovulate, suggesting immature hormonal regulation rather than a specific condition.

High androgen levels in Chinese women with PCOS are linked to a higher risk of diabetes and obesity.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Hormonal therapies are safe and effective for treating adult women's acne.

Drug repositioning is becoming more targeted and efficient with new technologies, offering personalized treatment options and growing interest in the field.

Early balding men may have insulin resistance, but lifestyle changes can help.

Fetal cells could improve skin repair with minimal scarring and are a potential ready-to-use solution for tissue engineering.

Finasteride and flutamide effectively reduce hirsutism in PCOS women, with flutamide also lowering hormone levels.

The review found no clear link between vitamin D receptor gene variations and polycystic ovary syndrome.

Testosterone may help increase sexual events for women with low libido due to antidepressants.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Herbal compounds like ricinoleic acid, quercetin-3-O-rutinoside, and hinokiflavone may be safe and effective for treating hair loss.

The conclusion suggests a possible link between iron levels and hair health in women, recommending further research on iron supplementation for hair loss.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Women with PCOS who had antiandrogenic treatment before pregnancy had fewer complications than those without treatment.

High levels of TNF-α may contribute to obesity and insulin resistance in PCOS, but not due to the C850T genetic variation.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Certain Chinese herbs, especially Cacumen platycladi, can promote hair regrowth and reduce hair loss-related hormone levels in mice.

Thyroid diseases may contribute to autoimmune skin diseases, and more research is needed on their relationship.

To stop online sexism, both men and women need to change how they act.

Recognizing and treating skin symptoms in essential thrombocythemia is crucial for patient quality of life.

Acne severity in women with PCOS is linked to younger age, lower body weight, and more body hair, but not to hormone levels.

Testosterone implants in women require pharmacological dosing to be effective and are generally safe and well-tolerated.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

The superficial temporal artery flap is a reliable method for reconstructing complex facial defects with minimal complications.

Women with AGA have more androstenedione and dihydrotestosterone, less copper and zinc; copper imbalance affects AGA; treatment improves hormones and minerals.

Finasteride works better for hair loss in patients 26 or younger.